The newly added medicines include two for type 2 diabetes, Jentadueto and Jentadueto XR, and one for chronic obstructive ...

Chronic obstructive pulmonary disease, or COPD, is the 5th-leading cause of death in the United States and the cause of more ...

Patients with COPD and coexisting OSAS have greater impairments in muscle quality and physical performance than those with isolated COPD.

The researchers noted that their results do not support the hypothesis that blocking vitamin K–dependent pathways worsens ...

Escalating to extrafine single-inhaler triple therapy significantly reduces exacerbations in patients with moderate to severe COPD.

You did it to yourself.” This is one of the things that patients who are diagnosed with COPD often hear because of the stigma ...

New long-acting muscarinic antagonist-long-acting beta agonist users had a decreased risk for a first moderate/severe COPD ...

Asthma and COPD patients in the UK are set to receive faster, community-based care under a £10 million NHS initiative, ...

Patients with COPD and heart failure treated with SGLT-2 inhibitors experienced higher rates of volume depletion and adverse renal events. Chronic obstructive pulmonary disease (COPD) reduces the ...

Chronic obstructive pulmonary disease (COPD) is a lung condition that often hides in plain sight. You may think you’re dealing with a common cold, when in reality, your lungs are swollen, irritated ...

Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Cl ...

COPD affects at least 4.5% of those 18-49 years old, according to an analysis of U.S. cohorts. The early COPD group was more likely to be hospitalized or die from chronic respiratory disease, to ...